Hec Cj Pharm
Hec Cj Pharm, officially known as Hec Pharm Co., Ltd., is a prominent player in the pharmaceutical industry, headquartered in China (CN). Founded in 2001, the company has established a strong presence in major operational regions across Asia and beyond, focusing on the development and manufacturing of high-quality pharmaceutical products. Specialising in active pharmaceutical ingredients (APIs) and finished dosage forms, Hec Cj Pharm is recognised for its commitment to innovation and quality. The company’s unique approach combines advanced technology with rigorous quality control, ensuring that its products meet international standards. With a solid market position, Hec Cj Pharm has achieved notable milestones, including various certifications and partnerships that enhance its reputation in the global market. The company continues to expand its portfolio, contributing significantly to the healthcare sector.
DitchCarbon Score
How does Hec Cj Pharm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hec Cj Pharm's score of 22 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hec Cj Pharm's reported carbon emissions
In 2023, Hec Cj Pharm reported total carbon emissions of approximately 68,798,560 kg CO2e. This figure includes about 1,970 kg CO2e from Scope 1 emissions and about 68,796,590 kg CO2e from Scope 2 emissions. The company has shown a notable increase in emissions compared to 2022, when total emissions were approximately 62,205,490 kg CO2e, with Scope 1 emissions at about 1,100 kg CO2e and Scope 2 emissions at around 62,043,390 kg CO2e. Over the past few years, Hec Cj Pharm's emissions have fluctuated, with 2021 emissions recorded at approximately 63,666,380 kg CO2e, including about 35,060 kg CO2e from Scope 1 and approximately 63,631,330 kg CO2e from Scope 2. In 2020, the total emissions were about 42,527,430 kg CO2e, with Scope 1 emissions of approximately 46,670 kg CO2e and Scope 2 emissions of about 42,480,750 kg CO2e. The trend indicates a significant increase in emissions from 2019, when total emissions were around 34,606,960 kg CO2e. Currently, Hec Cj Pharm has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of such commitments suggests that the company may need to enhance its climate strategy to align with industry standards and expectations for carbon reduction.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 49,760 | 00,000 | 00,000 | 0,000 | 0,000 |
| Scope 2 | 34,606,960 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hec Cj Pharm is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
